Halozyme Therapeutics (HALO) Capital Expenditures (2010 - 2026)
Halozyme Therapeutics' Capital Expenditures came in at $4.17 million for Q2 2026, up 167.0% from $1.56 million a year earlier and up 11.5% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Capital Expenditures (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Halozyme Therapeutics reported Capital Expenditures of $12.37 million, up 74.7% year-over-year; for FY2025, it came in at $6.97 million, down 34.8% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of 22.7% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $10.7 million in FY2024 (-30.1%), $15.29 million in FY2023 (+218.0%), $4.81 million in FY2022 (+230.1%) and $1.46 million in FY2021 (-41.8%).
- The Q2 2026 figure represents the highest quarterly Capital Expenditures since Q1 2023.
- Year-over-year, Capital Expenditures increased in four of the last eight quarters, with growth averaging 45.5%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q1 2026 (growth of 293.8%), and the weakest in Q4 2021 (a decline of 90.7%).
- Business Quant data shows HALO's Capital Expenditures at $3.74 million (Q1 2026), $1.43 million (Q4 2025) and $3.03 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn | 4.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.17 Mn |
| Mar 31, 2026 | 3.74 Mn |
| Dec 31, 2025 | 1.43 Mn |
| Sep 30, 2025 | 3.03 Mn |
| Jun 30, 2025 | 1.56 Mn |
| Mar 31, 2025 | 950,000.00 |
| Dec 31, 2024 | 3.05 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 2.58 Mn |
| Mar 31, 2024 | 3.55 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Sep 30, 2023 | 2.94 Mn |
| Jun 30, 2023 | -1.62 Mn |
| Mar 31, 2023 | 11.38 Mn |
| Dec 31, 2022 | 2.34 Mn |
| Sep 30, 2022 | 1.01 Mn |
| Jun 30, 2022 | 968,000.00 |
| Mar 31, 2022 | 490,000.00 |
| Dec 31, 2021 | 158,000.00 |
| Sep 30, 2021 | 496,000.00 |
API Access
Halozyme Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();